Chad M. Cohen - Dec 22, 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
Chief Financial Officer
Signature
/s/ Chad Cohen by Eric Billings, Attorney-in-Fact
Stock symbol
ADPT
Transactions as of
Dec 22, 2021
Transactions value $
-$227,300
Form type
4
Date filed
12/23/2021, 08:00 PM
Previous filing
Dec 7, 2021
Next filing
May 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Options Exercise $72.7K +10K +46.29% $7.27 31.6K Dec 22, 2021 Direct F1
transaction ADPT Common Stock Sale -$300K -10K -31.64% $30.00 21.6K Dec 22, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADPT Stock Option (Right to Buy) Options Exercise $0 -10K -11.11% $0.00 80K Dec 22, 2021 Common Stock 10K $7.27 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
F2 The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.